Healthcare · Biotechnology · NASDAQ
| Market cap | $1.67B |
|---|---|
| Trailing P/E | — |
| FCF yield | -30.6% |
| Revenue growth (YoY) | +16.9% |
| EPS growth (YoY) | — |
| FCF/share growth (YoY) | — |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
Intellia Therapeutics, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Donald Sternoff Beyer | House | Sell | $15,001 - $50,000 | Mar 1, 2022 |
| Donald Sternoff Honorable Beyer | House | Sell | $1,001 - $15,000 | Oct 30, 2021 |
| Donald Sternoff Honorable Beyer | House | Sell | $1,001 - $15,000 | Oct 1, 2021 |
| Donald Sternoff Honorable Beyer | House | Sell | $1,001 - $15,000 | Jul 25, 2021 |
| Donald Sternoff Honorable Beyer | House | Sell | $1,001 - $15,000 | Jan 28, 2021 |
| Thomas R Carper | Senate | Buy | $1,001 - $15,000 | — |
| Donald Sternoff Beyer | House | Buy | $1,001 - $15,000 | Nov 18, 2020 |
| Donald Sternoff Beyer | House | Sell | $1,001 - $15,000 | Sep 3, 2020 |
| Donald Sternoff Beyer | House | Buy | $1,001 - $15,000 | Aug 1, 2020 |
| Donald Sternoff Beyer | House | Buy | $1,001 - $15,000 | Feb 2, 2020 |
| Donald Sternoff Beyer | House | Buy | $1,001 - $15,000 | Dec 14, 2019 |
| James M Inhofe | Senate | Sell | $15,001 - $50,000 | — |